The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Urine Based Glucose Monitoring Market Research Report 2024
Synopsis
Urine-based glucose monitoring is a method used to measure glucose levels in urine samples. While not as accurate as blood-based monitoring, urine testing can provide an indication of glucose levels and help in diabetes management.
The global Urine Based Glucose Monitoring market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for urine-based glucose monitoring is driven by factors such as its simplicity and cost-effectiveness, making it a viable option in certain healthcare settings or resource-limited environments. However, the growing popularity of blood-based and non-invasive glucose monitoring methods may impact the market's growth in the long term.
This report aims to provide a comprehensive presentation of the global market for Urine Based Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urine Based Glucose Monitoring.
Report Scope
The Urine Based Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urine Based Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urine Based Glucose Monitoring manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Segment by Type
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Urine Based Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Urine Based Glucose Monitoring in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Urine-based glucose monitoring is a method used to measure glucose levels in urine samples. While not as accurate as blood-based monitoring, urine testing can provide an indication of glucose levels and help in diabetes management.
The global Urine Based Glucose Monitoring market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for urine-based glucose monitoring is driven by factors such as its simplicity and cost-effectiveness, making it a viable option in certain healthcare settings or resource-limited environments. However, the growing popularity of blood-based and non-invasive glucose monitoring methods may impact the market's growth in the long term.
This report aims to provide a comprehensive presentation of the global market for Urine Based Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urine Based Glucose Monitoring.
Report Scope
The Urine Based Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urine Based Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urine Based Glucose Monitoring manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Segment by Type
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Urine Based Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Urine Based Glucose Monitoring in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Urine Based Glucose Monitoring Market Overview
1.1 Product Overview and Scope of Urine Based Glucose Monitoring
1.2 Urine Based Glucose Monitoring Segment by Type
1.2.1 Global Urine Based Glucose Monitoring Market Value Comparison by Type (2024-2030)
1.2.2 Wearable Blood Glucose Monitoring Systems
1.2.3 Table Top Blood Glucose Monitoring Systems
1.3 Urine Based Glucose Monitoring Segment by Application
1.3.1 Global Urine Based Glucose Monitoring Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Urine Based Glucose Monitoring Market Size Estimates and Forecasts
1.4.1 Global Urine Based Glucose Monitoring Revenue 2019-2030
1.4.2 Global Urine Based Glucose Monitoring Sales 2019-2030
1.4.3 Global Urine Based Glucose Monitoring Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Urine Based Glucose Monitoring Market Competition by Manufacturers
2.1 Global Urine Based Glucose Monitoring Sales Market Share by Manufacturers (2019-2024)
2.2 Global Urine Based Glucose Monitoring Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Urine Based Glucose Monitoring Average Price by Manufacturers (2019-2024)
2.4 Global Urine Based Glucose Monitoring Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Urine Based Glucose Monitoring, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Urine Based Glucose Monitoring, Product Type & Application
2.7 Urine Based Glucose Monitoring Market Competitive Situation and Trends
2.7.1 Urine Based Glucose Monitoring Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Urine Based Glucose Monitoring Players Market Share by Revenue
2.7.3 Global Urine Based Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Urine Based Glucose Monitoring Retrospective Market Scenario by Region
3.1 Global Urine Based Glucose Monitoring Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Urine Based Glucose Monitoring Global Urine Based Glucose Monitoring Sales by Region: 2019-2030
3.2.1 Global Urine Based Glucose Monitoring Sales by Region: 2019-2024
3.2.2 Global Urine Based Glucose Monitoring Sales by Region: 2025-2030
3.3 Global Urine Based Glucose Monitoring Global Urine Based Glucose Monitoring Revenue by Region: 2019-2030
3.3.1 Global Urine Based Glucose Monitoring Revenue by Region: 2019-2024
3.3.2 Global Urine Based Glucose Monitoring Revenue by Region: 2025-2030
3.4 North America Urine Based Glucose Monitoring Market Facts & Figures by Country
3.4.1 North America Urine Based Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Urine Based Glucose Monitoring Sales by Country (2019-2030)
3.4.3 North America Urine Based Glucose Monitoring Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Urine Based Glucose Monitoring Market Facts & Figures by Country
3.5.1 Europe Urine Based Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Urine Based Glucose Monitoring Sales by Country (2019-2030)
3.5.3 Europe Urine Based Glucose Monitoring Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Urine Based Glucose Monitoring Market Facts & Figures by Country
3.6.1 Asia Pacific Urine Based Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Urine Based Glucose Monitoring Sales by Country (2019-2030)
3.6.3 Asia Pacific Urine Based Glucose Monitoring Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Urine Based Glucose Monitoring Market Facts & Figures by Country
3.7.1 Latin America Urine Based Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Urine Based Glucose Monitoring Sales by Country (2019-2030)
3.7.3 Latin America Urine Based Glucose Monitoring Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Urine Based Glucose Monitoring Market Facts & Figures by Country
3.8.1 Middle East and Africa Urine Based Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Urine Based Glucose Monitoring Sales by Country (2019-2030)
3.8.3 Middle East and Africa Urine Based Glucose Monitoring Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Urine Based Glucose Monitoring Sales by Type (2019-2030)
4.1.1 Global Urine Based Glucose Monitoring Sales by Type (2019-2024)
4.1.2 Global Urine Based Glucose Monitoring Sales by Type (2025-2030)
4.1.3 Global Urine Based Glucose Monitoring Sales Market Share by Type (2019-2030)
4.2 Global Urine Based Glucose Monitoring Revenue by Type (2019-2030)
4.2.1 Global Urine Based Glucose Monitoring Revenue by Type (2019-2024)
4.2.2 Global Urine Based Glucose Monitoring Revenue by Type (2025-2030)
4.2.3 Global Urine Based Glucose Monitoring Revenue Market Share by Type (2019-2030)
4.3 Global Urine Based Glucose Monitoring Price by Type (2019-2030)
5 Segment by Application
5.1 Global Urine Based Glucose Monitoring Sales by Application (2019-2030)
5.1.1 Global Urine Based Glucose Monitoring Sales by Application (2019-2024)
5.1.2 Global Urine Based Glucose Monitoring Sales by Application (2025-2030)
5.1.3 Global Urine Based Glucose Monitoring Sales Market Share by Application (2019-2030)
5.2 Global Urine Based Glucose Monitoring Revenue by Application (2019-2030)
5.2.1 Global Urine Based Glucose Monitoring Revenue by Application (2019-2024)
5.2.2 Global Urine Based Glucose Monitoring Revenue by Application (2025-2030)
5.2.3 Global Urine Based Glucose Monitoring Revenue Market Share by Application (2019-2030)
5.3 Global Urine Based Glucose Monitoring Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Urine Based Glucose Monitoring Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Urine Based Glucose Monitoring Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Urine Based Glucose Monitoring Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Bayer AG
6.4.1 Bayer AG Corporation Information
6.4.2 Bayer AG Description and Business Overview
6.4.3 Bayer AG Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer AG Urine Based Glucose Monitoring Product Portfolio
6.4.5 Bayer AG Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B. Braun Urine Based Glucose Monitoring Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Nipro Diagnostics
6.6.1 Nipro Diagnostics Corporation Information
6.6.2 Nipro Diagnostics Description and Business Overview
6.6.3 Nipro Diagnostics Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nipro Diagnostics Urine Based Glucose Monitoring Product Portfolio
6.6.5 Nipro Diagnostics Recent Developments/Updates
6.7 Life Scan Inc.(J&J)
6.6.1 Life Scan Inc.(J&J) Corporation Information
6.6.2 Life Scan Inc.(J&J) Description and Business Overview
6.6.3 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Product Portfolio
6.7.5 Life Scan Inc.(J&J) Recent Developments/Updates
6.8 Arkray Devices
6.8.1 Arkray Devices Corporation Information
6.8.2 Arkray Devices Description and Business Overview
6.8.3 Arkray Devices Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Arkray Devices Urine Based Glucose Monitoring Product Portfolio
6.8.5 Arkray Devices Recent Developments/Updates
6.9 Nova Biomedical
6.9.1 Nova Biomedical Corporation Information
6.9.2 Nova Biomedical Description and Business Overview
6.9.3 Nova Biomedical Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nova Biomedical Urine Based Glucose Monitoring Product Portfolio
6.9.5 Nova Biomedical Recent Developments/Updates
6.10 Bionime Corporation
6.10.1 Bionime Corporation Corporation Information
6.10.2 Bionime Corporation Description and Business Overview
6.10.3 Bionime Corporation Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bionime Corporation Urine Based Glucose Monitoring Product Portfolio
6.10.5 Bionime Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Urine Based Glucose Monitoring Industry Chain Analysis
7.2 Urine Based Glucose Monitoring Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Urine Based Glucose Monitoring Production Mode & Process
7.4 Urine Based Glucose Monitoring Sales and Marketing
7.4.1 Urine Based Glucose Monitoring Sales Channels
7.4.2 Urine Based Glucose Monitoring Distributors
7.5 Urine Based Glucose Monitoring Customers
8 Urine Based Glucose Monitoring Market Dynamics
8.1 Urine Based Glucose Monitoring Industry Trends
8.2 Urine Based Glucose Monitoring Market Drivers
8.3 Urine Based Glucose Monitoring Market Challenges
8.4 Urine Based Glucose Monitoring Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
